| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.2726 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.3123 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.3505 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.3536 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.3595 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.3960 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4100 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4121 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4210 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4386 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4412 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4517 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4600 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4628 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.4975 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.5067 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.5069 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.5101 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.5367 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.5560 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.5700 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.5857 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.6157 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.6204 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.6438 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.6534 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.6603 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7077 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7155 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7211 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7474 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7506 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7550 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7558 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7579 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7670 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7736 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7776 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7865 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7904 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7923 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.7949 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8023 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8041 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8080 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8123 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8125 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8196 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8225 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8271 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8306 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8388 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8424 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8450 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8455 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8491 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8514 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8522 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8536 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8537 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8551 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8576 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8589 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8614 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8614 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8666 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8726 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8747 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8772 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8835 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8871 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.8917 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9013 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9021 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9053 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9061 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9169 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9180 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9185 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9220 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9251 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9288 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9316 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9561 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9562 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9575 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9600 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9640 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9641 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9731 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9821 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9834 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 0.9981 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0000 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0013 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0108 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0119 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0179 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0206 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0223 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0227 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0232 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0360 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0406 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0459 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0461 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0473 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0473 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0605 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0622 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0723 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0783 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.0998 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1022 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1054 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1080 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1129 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1134 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1149 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1154 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1173 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1312 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1322 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1346 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1370 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1426 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1445 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1759 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1760 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1811 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1926 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.1971 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2109 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2191 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2236 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2366 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2450 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2471 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2486 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2488 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2491 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2599 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2616 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2626 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2814 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2832 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.2920 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3062 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3077 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3088 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3090 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3118 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3160 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3199 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3278 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3442 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3481 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3573 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3580 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3632 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3670 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3704 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3729 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3855 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.3859 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.4033 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.4063 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.4836 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.4937 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.5505 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.5541 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.5718 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.6098 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.6364 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.6626 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.7020 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.7223 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.7487 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.7545 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.7931 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 1.8310 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 2.0013 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 2.1715 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 2.3974 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | nicotinamide | 2.6242 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | nicotinamide | 3.3182 | scaled units | Low-Dose | +4HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|